Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Saudi Arabia
/
Pharmaceuticals & Biotech
Create a narrative
Jamjoom Pharmaceuticals Factory Community
SASE:4015 Community
1
Narratives
written by author
0
Comments
on narratives written by author
16
Fair Values set
on narratives written by author
Create a narrative
Jamjoom Pharmaceuticals Factory
Popular
Undervalued
Overvalued
Community Investing Ideas
Jamjoom Pharmaceuticals Factory
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Facilities In Jeddah Egypt And Algeria Will Expand MENA Markets
Key Takeaways Expanding production capacity, strategic market entries, and international partnerships are driving operational efficiency, revenue growth, and geographic diversification. Shifting toward high-margin branded generics and specialty drugs, supported by a strong product pipeline, is boosting profitability and positioning for sustained earnings growth.
View narrative
ر.س178.20
FV
9.4% undervalued
intrinsic discount
13.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
4015
4015
Jamjoom Pharmaceuticals Factory
Your Fair Value
ر.س
Current Price
ر.س161.40
42.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
2b
2015
2018
2021
2024
2025
2027
2030
Revenue ر.س2.3b
Earnings ر.س684.7m
Advanced
Set Fair Value